DTIL Precision BioSciences Inc.: Company Book Value

Public company logo of Precision BioSciences, Inc. (DTIL)

Precision BioSciences (DTIL) automates genome editing via ARCUS AI systems, eliminating routine tasks for researchers. This daily price chart reflects a level of 0.04. The business relies on exclusive software for combating genetic pathologies, secured through partnerships with industry behemoths. High human capital potential is ensured by attracting top biologists, who are guaranteed competitive compensation and development budgets.

precisionbiosciences.com (DTIL) - Company Book Value from 07/04/2022 to 10/27/2026

Analytical breakdowns for Precision BioSciences

- price and consensus price forecast:
Market Chart precisionbiosciences.com|DTIL - Price Target Chart
- market capitalization data:
Market Value Precision BioSciences Inc.|DTIL - Enterprise Value
- book capitalization data:
Equity per Share Precision BioSciences|DTIL - Company Book Value|Capitalization to Book Value Ratio precisionbiosciences.com|DTIL - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Precision BioSciences|DTIL - Long-Term Debt to Equity|Current Liabilities to Equity Precision BioSciences Inc.|DTIL - Company Debts|Debt to Net Assets Ratio Precision BioSciences Inc.
Fundamental company analysis:DTIL - precisionbiosciences.com
Flagship merchandise of Precision BioSciences Inc.

For Precision BioSciences (DTIL), which monetizes its ARCUS platform through licensing fees from pharma behemoths, the company's accounting capitalization history reflects the actual dynamics of accumulated net assets. This indicator is calculated as the difference between all assets and liabilities, serving as a fundamental filter against market overvaluations and allowing investors to assess the intrinsic value of the business independently of speculative optimism in share prices.

Key competitors

TEM: Book Valuation of Business|Qiagen N.V. (QGEN) - Company Book Value|ionispharma.com (IONS) - Company Book Value|Book Capitalization Repligen (RGEN)|Accounting Capitalization RNA|Company Book Value CRISPR Therapeutics Corp CRSP|Accounting Capitalization GeneDx Corp (WGS)|Book Capitalization RARE (Ultragenyx Pharmaceutical)|beamtx.com - Book Capitalization|Company Book Value Sarepta|TWST: Net Asset Value|Company Book Value 10x Genomics Corp TXG|Intellia Corp (NTLA) - Accounting Value of Company|Book Capitalization STOK (Stoke Therapeutics)|Total Stockholders' Equity biolifesolutions.com|Book Capitalization WVE (Wave Life Sciences Ltd.)|Company Net Assets Maze Therapeutics, Inc. (MAZE)|Book Capitalization SION|Prime Medicine Bio - Book Valuation of Business|Company Book Value TSHA (Taysha Gene Therapies)|QURE - Book Valuation of Business|MeiraGTx - Book Capitalization|RGNX (REGENXBIO Inc) - Book Valuation of Business|Company Book Value SLDB (Solid Bio)|Total Stockholders' Equity OCGN|Company Book Value Pacific Biosciences PACB|Accounting Capitalization benitec.com BNTC|Company Net Assets Design Therapeutics, Inc.|Accounting Value of Company Rocket Pharma RCKT|FDMT - Book Capitalization|LXEO - Company Book Value|korrobio.com - Book Capitalization|EDIT (editasmedicine.com) - Book Valuation of Business|Company Book Value SLN (Silence Therapeutics plc)|Total Stockholders' Equity PRQR|CDXS (Codexis, Inc.) - Company Book Value|Book Valuation of Business Sangamo BioSciences (SGMO)|Nautilus Bio - Book Capitalization|Company Net Assets metagenomi.co MGX|Book Capitalization GBIO (Generation Bio Corp)|BOLD - Book Valuation of Business|Book Capitalization XCUR|IMNN (Imunon) - Total Stockholders' Equity|Company Book Value Phio Pharmaceuticals Corp (PHIO)|Accounting Capitalization Mustang Bio Corp|Book Capitalization RNAZ (TransCode Therapeutics)|Company Net Assets bionanogenomics.com (BNGO)|APDN: Book Capitalization|bluebird bio, Inc - Total Stockholders' Equity|Company Book Value IPA (ImmunoPrecise)|OMGA - Book Valuation of Business|Book Capitalization Singular Genomics|Accounting Capitalization Regulus Therapeutics, Inc.|Syros (SYRS) - Company Net Assets|Total Net Assets Telesis Bio, Inc|TCON (TRACON Pharmaceuticals) - Book Capitalization|Book Valuation of Business UBX (unitybiotechnology.com)